跳至主要内容
临床试验/NCT05487469
NCT05487469Unknown不适用

Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
The highest Sequential Organ Failure Assessment (SOFA) score of 5 days after surgery

研究概览

简要总结

Rheumatic heart disease usually accompanied by weakened immune function. And the cardiopulmonary bypass further aggravating the decline of immune function. Therefore, the prevention of Postoperative immune function collapse is of great clinical value, and immunomodulatory therapy with thymosin alpha

1 may be beneficial. This study was designed to test the hypothesis that the administration of thymosin alpha 1 will Improve the immune function and prognosis of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patients are conformed to 2004 WHO guidelines for Rheumatic fever and rheumatic heart disease;
  • Patients planning to undergo cardiac surgery were enrolled.
  • The patients' age between 18 ~80 years old.
  • Agree to participate in the study and sign the informed consent.

排除标准

  • Patients allergic to Thymosin α1;
  • Lactating women and pregnant women;
  • Patients with mental diseases, drug and alcohol dependence;
  • Refuse to participate in this study and refuse to sign the informed consent

研究组 & 干预措施

Thymosin alpha 1

Experimental

干预措施: Thymosin Alpha1 (Drug)

Blank control

Sham Comparator

干预措施: Blank Control (Other)

结局指标

主要结局

The highest Sequential Organ Failure Assessment (SOFA) score of 5 days after surgery

时间窗: 5 days after surgery

次要结局

  • 30-day mortality(30 days after randomization)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Liu

Principal Investigator of Cardiovascular Surgery

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验